Emergence and phylogenetic analysis of amantadine-resistant influenza a subtype H3N2 viruses in Dublin, Ireland, over six seasons from 2003/2004 to 2008/2009

Intervirology

Volumn 54, Issue 6, 2011, Pages 305-315

  Salter, A ^a,b   Ni Laoi, B ^b   Crowley, B ^b,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amantadine resistance; Antigenic variations; Clades S and N; Haemagglutinin gene; Irish influenza A viruses; Matrix 2 gene; Phylogenetic analysis

Indexed keywords

AMANTADINE; HEMAGGLUTININ; PROTEIN M2; VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; CLADISTICS; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENOTYPE; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; IRELAND; LONGITUDINAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; VIRUS GENE; VIRUS ISOLATION;

AMANTADINE; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; GENETIC DRIFT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; IRELAND; LIKELIHOOD FUNCTIONS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; VIRAL MATRIX PROTEINS;

INFLUENZA A VIRUS;

EID: 80053992617     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000321358     Document Type: Article

References (26)

1. Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ: Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol 1988; 62: 1508-1512.
2. Gubareva LV, Kaiser L, Hayden FG: Influenza virus neuraminidase inhibitors. Lancet 2000; 355: 827-835. (Pubitemid 30128828)
3. Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr: Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981; 245: 1128-1131. (Pubitemid 11095959)
4. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI: Adamantane resistance among influenza A viruses isolated early during the 2005-2006. influenza season in the United States. JAMA 2006; 295: 891-894.
5. Saito R, Li D, Suzuki Y, Sato I, Masaki H, Nishimura H, Kawashima T, Shirahige Y, Shimomura C, Asoh N, Degawa S, Ishikawa H, Sato M, Shobugawa Y, Suzuki H: High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season. J Med Virol 2007; 79: 1569-1576. (Pubitemid 47328746)
6. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI: Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007; 196: 249-257. (Pubitemid 47047464)
7. Swofford DL: PAUP * : Phylogenetic Analysis Using Parsimony ( * and other methods). Version 40b10. Sunderland, Sinaur Associates Inc., 2002.
8. Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics 1998; 14: 817-818. (Pubitemid 28552116)
9. Tang JW, Ngai KL, Wong JC, Lam WY, Chan PK: Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997. and 2006. J Med Virol 2008; 80: 895-901. (Pubitemid 351500039)
10. Saito R, Li D, Shimomura C, Masaki H, Le MQ, Nguyen HL, Nguyen HT, Phan TV, Nguyen TT, Sato M, Suzuki Y, Suzuki H: An off-seasonal amantadine-resistant H3N2 influenza outbreak in Japan. Tohoku J Exp Med 2006; 210: 21-27. (Pubitemid 44377785)
11. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM: Predicting the evolution of human influenza A. Science 1999; 286: 1921-1925. (Pubitemid 129515893)
12. Wiley DC, Wilson IA, Skehel JJ: Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981; 289: 373-378. (Pubitemid 11135143)
13. Li D, Saito R, Le MT, Nguyen HL, Suzuki Y, Shobugawa Y, Dinh DT, Hoang PV, Tran HT, Nghiem HK, Hoang LT, Huynh LP, Nguyen HT, Nishikawa M, Suzuki H: Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008; 46: 399-405. (Pubitemid 351231278)
14. WHO: WHO Recommended composition of influenza virus vaccines for use in the 2005-2006. influenza season. Weekly Epidemiol Record 2005; 80: 71-75.
15. Schmidtke M, Zell R, Bauer K, Krumbholz A, Schrader C, Suess J, Wutzler P: Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology 2006; 49: 286-293.
16. Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005; 366: 1175-1181. (Pubitemid 41393595)
17. Ilyushina NA, Bovin NV, Webster RG, Govorkova EA: Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Res 2006; 70: 121-131. (Pubitemid 43765615)
18. CDC: High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. MMWR Morb Mortal Wkly Rep 2006; 55: 44-46.
19. Saito R, Sakai T, Sato I, Sano Y, Oshitani H, Sato M, Suzuki H: Frequency of amantadineresistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2. J Clin Microbiol 2003; 41: 2164-2165. (Pubitemid 36576555)
20. Abed Y, Goyette N, Boivin G: Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005; 49: 556-559. (Pubitemid 40175661)
21. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, St George K, Grenfell BT, Salzberg SL, Fraser CM, Lipman DJ, Taubenberger JK: Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 2005; 3:e300.
22. Gog JR, Rimmelzwaan GF, Osterhaus AD, Grenfell BT: Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci USA 2003; 100: 11143-11147. (Pubitemid 37140166)
23. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller MA, Holmes EC: The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 2007; 24: 1811-1820. (Pubitemid 47236702)
24. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, Oshitani H: Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 2009; 47: 841-844.
25. Jonges M, van der Lubben IM, Dijkstra F, Verhoef L, Koopmans M, Meijer A: Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral Res 2009; 83: 290-297.
26. Medeiros R, Naffakh N, Manuguerra JC, van der Werf S: Binding of the hemagglutinin from human or equine influenza H3 viruses to the receptor is altered by substitutions at residue 193. Arch Virol 2004; 149: 1663-1671. (Pubitemid 39059517)